{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "ae2121b0",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "c:\\Users\\Sony\\Desktop\\KaggleXGoogle\\.venv\\lib\\site-packages\\google\\api_core\\_python_version_support.py:266: FutureWarning: You are using a Python version (3.10.0) which Google will stop supporting in new releases of google.api_core once it reaches its end of life (2026-10-04). Please upgrade to the latest Python version, or at least Python 3.11, to continue receiving updates for google.api_core past that date.\n",
      "  warnings.warn(message, FutureWarning)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "‚úÖ ADK components imported successfully.\n"
     ]
    }
   ],
   "source": [
    "from typing import Any, Dict\n",
    "\n",
    "from google.adk.agents import Agent, LlmAgent\n",
    "from google.adk.apps.app import App, EventsCompactionConfig\n",
    "from google.adk.models.google_llm import Gemini\n",
    "from google.adk.sessions import DatabaseSessionService\n",
    "from google.adk.sessions import InMemorySessionService\n",
    "from google.adk.runners import Runner\n",
    "from google.adk.tools.tool_context import ToolContext\n",
    "from google.genai import types\n",
    "\n",
    "print(\"‚úÖ ADK components imported successfully.\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "13db9098",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "‚úÖ Helper functions defined.\n"
     ]
    }
   ],
   "source": [
    "async def run_session(\n",
    "    runner_instance: Runner,\n",
    "    user_queries: list[str] | str = None,\n",
    "    session_name: str = \"default\",\n",
    "):\n",
    "    print(f\"\\n ### Session: {session_name}\")\n",
    "\n",
    "    # Get app name from the Runner\n",
    "    app_name = runner_instance.app_name\n",
    "\n",
    "    # Attempt to create a new session or retrieve an existing one\n",
    "    try:\n",
    "        session = await session_service.create_session(\n",
    "            app_name=app_name, user_id=USER_ID, session_id=session_name\n",
    "        )\n",
    "    except:\n",
    "        session = await session_service.get_session(\n",
    "            app_name=app_name, user_id=USER_ID, session_id=session_name\n",
    "        )\n",
    "\n",
    "    # Process queries if provided\n",
    "    if user_queries:\n",
    "        # Convert single query to list for uniform processing\n",
    "        if type(user_queries) == str:\n",
    "            user_queries = [user_queries]\n",
    "\n",
    "        # Process each query in the list sequentially\n",
    "        for query in user_queries:\n",
    "            print(f\"\\nUser > {query}\")\n",
    "\n",
    "            # Convert the query string to the ADK Content format\n",
    "            query = types.Content(role=\"user\", parts=[types.Part(text=query)])\n",
    "\n",
    "            # Stream the agent's response asynchronously\n",
    "            async for event in runner_instance.run_async(\n",
    "                user_id=USER_ID, session_id=session.id, new_message=query\n",
    "            ):\n",
    "                # Check if the event contains valid content\n",
    "                if event.content and event.content.parts:\n",
    "                    # Filter out empty or \"None\" responses before printing\n",
    "                    if (\n",
    "                        event.content.parts[0].text != \"None\"\n",
    "                        and event.content.parts[0].text\n",
    "                    ):\n",
    "                        print(f\"{MODEL_NAME} > \", event.content.parts[0].text)\n",
    "    else:\n",
    "        print(\"No queries!\")\n",
    "\n",
    "\n",
    "print(\"‚úÖ Helper functions defined.\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "372a3c6d",
   "metadata": {},
   "outputs": [],
   "source": [
    "retry_config = types.HttpRetryOptions(\n",
    "    attempts=5,  # Maximum retry attempts\n",
    "    exp_base=7,  # Delay multiplier\n",
    "    initial_delay=1,\n",
    "    http_status_codes=[429, 500, 503, 504],  # Retry on these HTTP errors\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "a6c623ed",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "‚úÖ Stateful agent initialized!\n",
      "   - Application: default\n",
      "   - User: default\n",
      "   - Using: InMemorySessionService\n"
     ]
    }
   ],
   "source": [
    "APP_NAME = \"default\"  # Application\n",
    "USER_ID = \"default\"  # User\n",
    "SESSION = \"default\"  # Session\n",
    "\n",
    "MODEL_NAME = \"gemini-2.5-flash-lite\"\n",
    "\n",
    "\n",
    "# Step 1: Create the LLM Agent\n",
    "root_agent = Agent(\n",
    "    model=Gemini(model=\"gemini-2.5-flash-lite\", retry_options=retry_config),\n",
    "    name=\"text_chat_bot\",\n",
    "    description=\"A text chatbot\",  # Description of the agent's purpose\n",
    ")\n",
    "\n",
    "# Step 2: Set up Session Management\n",
    "# InMemorySessionService stores conversations in RAM (temporary)\n",
    "session_service = InMemorySessionService()\n",
    "\n",
    "# Step 3: Create the Runner\n",
    "runner = Runner(agent=root_agent, app_name=APP_NAME, session_service=session_service)\n",
    "\n",
    "print(\"‚úÖ Stateful agent initialized!\")\n",
    "print(f\"   - Application: {APP_NAME}\")\n",
    "print(f\"   - User: {USER_ID}\")\n",
    "print(f\"   - Using: {session_service.__class__.__name__}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "ab6c40cb",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      " ### Session: stateful-agentic-session\n",
      "\n",
      "User > Hi, I am Sam! What is the capital of United States?\n",
      "gemini-2.5-flash-lite >  Hi Sam! The capital of the United States is Washington, D.C.\n",
      "\n",
      "User > Hello! What is my name?\n",
      "gemini-2.5-flash-lite >  You told me your name is Sam!\n"
     ]
    }
   ],
   "source": [
    "# Run a conversation with two queries in the same session\n",
    "# Notice: Both queries are part of the SAME session, so context is maintained\n",
    "await run_session(\n",
    "    runner,\n",
    "    [\n",
    "        \"Hi, I am Sam! What is the capital of United States?\",\n",
    "        \"Hello! What is my name?\",  # This time, the agent should remember!\n",
    "    ],\n",
    "    \"stateful-agentic-session\",\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "23beec45",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "‚úÖ Upgraded to persistent sessions!\n",
      "   - Database: my_agent_data.db\n",
      "   - Sessions will survive restarts!\n"
     ]
    }
   ],
   "source": [
    "# Step 1: Create the same agent (notice we use LlmAgent this time)\n",
    "chatbot_agent = LlmAgent(\n",
    "    model=Gemini(model=\"gemini-2.5-flash-lite\", retry_options=retry_config),\n",
    "    name=\"text_chat_bot\",\n",
    "    description=\"A text chatbot with persistent memory\",\n",
    ")\n",
    "\n",
    "# Step 2: Switch to DatabaseSessionService\n",
    "# SQLite database will be created automatically\n",
    "db_url = \"sqlite:///my_agent_data.db\"  # Local SQLite file\n",
    "session_service = DatabaseSessionService(db_url=db_url)\n",
    "\n",
    "# Step 3: Create a new runner with persistent storage\n",
    "runner = Runner(agent=chatbot_agent, app_name=APP_NAME, session_service=session_service)\n",
    "\n",
    "print(\"‚úÖ Upgraded to persistent sessions!\")\n",
    "print(f\"   - Database: my_agent_data.db\")\n",
    "print(f\"   - Sessions will survive restarts!\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "694da88d",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      " ### Session: test-db-session-01\n",
      "\n",
      "User > Hi, I am Sam! What is the capital of the United States?\n",
      "gemini-2.5-flash-lite >  Hi Sam! The capital of the United States is Washington, D.C.\n",
      "\n",
      "User > Hello! What is my name?\n",
      "gemini-2.5-flash-lite >  Your name is Sam!\n"
     ]
    }
   ],
   "source": [
    "await run_session(\n",
    "    runner,\n",
    "    [\"Hi, I am Sam! What is the capital of the United States?\", \"Hello! What is my name?\"],\n",
    "    \"test-db-session-01\",\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "c793d638",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      " ### Session: test-db-session-01\n",
      "\n",
      "User > What is the capital of India?\n",
      "gemini-2.5-flash-lite >  The capital of India is New Delhi.\n",
      "\n",
      "User > Hello! What is my name?\n",
      "gemini-2.5-flash-lite >  Your name is Sam!\n"
     ]
    }
   ],
   "source": [
    "await run_session(\n",
    "    runner,\n",
    "    [\"What is the capital of India?\", \"Hello! What is my name?\"],\n",
    "    \"test-db-session-01\",\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "fee93de1",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      " ### Session: test-db-session-02\n",
      "\n",
      "User > What is the capital of India?\n",
      "gemini-2.5-flash-lite >  The capital of India is New Delhi.\n",
      "\n",
      "User > Hello! What is my name?\n",
      "gemini-2.5-flash-lite >  I do not have access to your personal information, including your name. I am a text-based chatbot and do not have the ability to know who you are.\n"
     ]
    }
   ],
   "source": [
    "await run_session(\n",
    "    runner,\n",
    "    [\"What is the capital of India?\", \"Hello! What is my name?\"],\n",
    "    \"test-db-session-02\",\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "f98b4281",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['app_name', 'session_id', 'author', 'content']\n",
      "('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"Hi, I am Sam! What is the capital of the United States?\"}], \"role\": \"user\"}')\n",
      "('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"Hi Sam! The capital of the United States is Washington, D.C.\"}], \"role\": \"model\"}')\n",
      "('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"Hello! What is my name?\"}], \"role\": \"user\"}')\n",
      "('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"Your name is Sam!\"}], \"role\": \"model\"}')\n",
      "('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"What is the capital of India?\"}], \"role\": \"user\"}')\n",
      "('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"The capital of India is New Delhi.\"}], \"role\": \"model\"}')\n",
      "('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"Hello! What is my name?\"}], \"role\": \"user\"}')\n",
      "('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"Your name is Sam!\"}], \"role\": \"model\"}')\n",
      "('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"What is the capital of India?\"}], \"role\": \"user\"}')\n",
      "('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"The capital of India is New Delhi.\"}], \"role\": \"model\"}')\n",
      "('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"Hello! What is my name?\"}], \"role\": \"user\"}')\n",
      "('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"Your name is Sam!\"}], \"role\": \"model\"}')\n",
      "('default', 'test-db-session-02', 'user', '{\"parts\": [{\"text\": \"What is the capital of India?\"}], \"role\": \"user\"}')\n",
      "('default', 'test-db-session-02', 'text_chat_bot', '{\"parts\": [{\"text\": \"The capital of India is New Delhi.\"}], \"role\": \"model\"}')\n",
      "('default', 'test-db-session-02', 'user', '{\"parts\": [{\"text\": \"Hello! What is my name?\"}], \"role\": \"user\"}')\n",
      "('default', 'test-db-session-02', 'text_chat_bot', '{\"parts\": [{\"text\": \"I do not have access to your personal information, including your name. I am a text-based chatbot and do not have the ability to know who you are.\"}], \"role\": \"model\"}')\n"
     ]
    }
   ],
   "source": [
    "import sqlite3\n",
    "\n",
    "def check_data_in_db():\n",
    "    with sqlite3.connect(\"my_agent_data.db\") as connection:\n",
    "        cursor = connection.cursor()\n",
    "        result = cursor.execute(\n",
    "            \"select app_name, session_id, author, content from events\"\n",
    "        )\n",
    "        print([_[0] for _ in result.description])\n",
    "        for each in result.fetchall():\n",
    "            print(each)\n",
    "\n",
    "\n",
    "check_data_in_db()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "defed13e",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "‚úÖ Research App upgraded with Events Compaction!\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\Sony\\AppData\\Local\\Temp\\ipykernel_10896\\3773147741.py:6: UserWarning: [EXPERIMENTAL] EventsCompactionConfig: This feature is experimental and may change or be removed in future versions without notice. It may introduce breaking changes at any time.\n",
      "  events_compaction_config=EventsCompactionConfig(\n"
     ]
    }
   ],
   "source": [
    "# Re-define our app with Events Compaction enabled\n",
    "research_app_compacting = App(\n",
    "    name=\"research_app_compacting\",\n",
    "    root_agent=chatbot_agent,\n",
    "    # This is the new part!\n",
    "    events_compaction_config=EventsCompactionConfig(\n",
    "        compaction_interval=3,  # Trigger compaction every 3 invocations\n",
    "        overlap_size=1,  # Keep 1 previous turn for context\n",
    "    ),\n",
    ")\n",
    "\n",
    "db_url = \"sqlite:///my_agent_data.db\"  # Local SQLite file\n",
    "session_service = DatabaseSessionService(db_url=db_url)\n",
    "\n",
    "# Create a new runner for our upgraded app\n",
    "research_runner_compacting = Runner(\n",
    "    app=research_app_compacting, session_service=session_service\n",
    ")\n",
    "\n",
    "\n",
    "print(\"‚úÖ Research App upgraded with Events Compaction!\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "1ac31140",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      " ### Session: compaction_demo\n",
      "\n",
      "User > What is the latest news about AI in healthcare?\n",
      "gemini-2.5-flash-lite >  The field of AI in healthcare is incredibly dynamic, so \"latest\" can change rapidly! However, here are some of the key areas where significant advancements and news are consistently emerging:\n",
      "\n",
      "**1. Drug Discovery and Development:**\n",
      "\n",
      "*   **Accelerated R&D:** AI is revolutionizing the time and cost associated with discovering new drugs. Companies are using AI to:\n",
      "    *   Identify potential drug candidates from vast molecular databases.\n",
      "    *   Predict how molecules will interact with biological targets.\n",
      "    *   Design novel drug compounds.\n",
      "    *   Optimize clinical trial design and patient selection.\n",
      "*   **Personalized Medicine:** AI is helping to tailor drug treatments to individual patients based on their genetic makeup, lifestyle, and disease characteristics.\n",
      "\n",
      "**2. Diagnostics and Imaging:**\n",
      "\n",
      "*   **Enhanced Image Analysis:** AI algorithms are becoming increasingly adept at analyzing medical images (X-rays, CT scans, MRIs, pathology slides) to detect subtle abnormalities that might be missed by the human eye. This is particularly impactful in:\n",
      "    *   **Radiology:** Detecting early signs of cancer, diabetic retinopathy, and other conditions.\n",
      "    *   **Pathology:** Identifying cancerous cells in tissue samples with high accuracy.\n",
      "*   **Predictive Diagnostics:** AI is being used to predict a patient's risk of developing certain diseases even before symptoms appear, allowing for earlier intervention.\n",
      "\n",
      "**3. Personalized Treatment and Patient Care:**\n",
      "\n",
      "*   **Treatment Recommendation Systems:** AI can analyze patient data to suggest the most effective treatment plans, considering factors like past treatments, comorbidities, and genetic profiles.\n",
      "*   **Remote Patient Monitoring:** Wearable devices and AI are enabling continuous monitoring of patients' vital signs and other health metrics, alerting healthcare providers to potential issues in real-time.\n",
      "*   **Virtual Assistants and Chatbots:** AI-powered chatbots are being used for:\n",
      "    *   Answering patient questions and providing health information.\n",
      "    *   Scheduling appointments.\n",
      "    *   Assisting with medication adherence.\n",
      "    *   Providing mental health support.\n",
      "\n",
      "**4. Operational Efficiency and Administrative Tasks:**\n",
      "\n",
      "*   **Streamlining Workflows:** AI can automate many administrative tasks, such as:\n",
      "    *   Medical coding and billing.\n",
      "    *   Processing insurance claims.\n",
      "    *   Managing electronic health records (EHRs).\n",
      "    *   Optimizing hospital resource allocation.\n",
      "*   **Reducing Burnout:** By taking over repetitive tasks, AI can free up healthcare professionals to focus on patient care, potentially reducing burnout.\n",
      "\n",
      "**5. Generative AI's Growing Role:**\n",
      "\n",
      "*   **Medical Content Generation:** Large language models (LLMs) are being explored for:\n",
      "    *   Summarizing patient records.\n",
      "    *   Drafting clinical notes.\n",
      "    *   Generating educational materials for patients and clinicians.\n",
      "    *   Assisting in research paper writing.\n",
      "*   **Synthetic Data Generation:** AI can create realistic synthetic medical data, which is invaluable for training AI models without compromising patient privacy.\n",
      "\n",
      "**Recent Trends and Areas of Focus:**\n",
      "\n",
      "*   **Explainable AI (XAI):** As AI becomes more integrated into critical healthcare decisions, there's a growing emphasis on making AI models understandable and transparent. Clinicians need to trust the AI's reasoning.\n",
      "*   **Regulatory Landscape:** Governments and regulatory bodies (like the FDA) are actively working to establish frameworks for the safe and effective deployment of AI in healthcare.\n",
      "*   **Ethical Considerations:** Discussions around data privacy, bias in AI algorithms, and the equitable access to AI-powered healthcare are becoming increasingly prominent.\n",
      "*   **Integration into Existing Systems:** A major challenge and focus is seamlessly integrating AI tools into existing hospital IT infrastructure and clinical workflows.\n",
      "*   **AI for Underserved Populations:** Efforts are being made to develop AI solutions that can improve healthcare access and outcomes for individuals in remote areas or with limited resources.\n",
      "\n",
      "**To get the absolute \"latest\" news, I would recommend checking out:**\n",
      "\n",
      "*   **Reputable healthcare technology news outlets:** Fierce Biotech, STAT News, Healthcare IT News, MedTech Dive, etc.\n",
      "*   **Major medical journals:** The Lancet, JAMA, NEJM, Nature Medicine, etc. (many have AI-specific sections or articles).\n",
      "*   **Conferences and events:** HIMSS, RSNA, JP Morgan Healthcare Conference, etc. (reports and summaries are often published).\n",
      "*   **Company announcements:** Major tech companies (Google, Microsoft, IBM) and healthcare AI startups often release news about their latest developments.\n",
      "\n",
      "The pace of innovation is incredible, so it's an exciting time to follow AI in healthcare!\n",
      "\n",
      " ### Session: compaction_demo\n",
      "\n",
      "User > Are there any new developments in drug discovery?\n",
      "gemini-2.5-flash-lite >  Yes, absolutely! Drug discovery is one of the most rapidly advancing areas where AI is making a significant impact. Here are some of the **key new developments and ongoing trends in AI-driven drug discovery**:\n",
      "\n",
      "**1. Deeper Understanding of Disease Biology:**\n",
      "\n",
      "*   **Multi-omics Integration:** AI is becoming more sophisticated at integrating data from various biological sources (genomics, proteomics, transcriptomics, metabolomics) to build a more comprehensive picture of disease mechanisms at a molecular level. This helps identify novel drug targets that might have been missed with traditional methods.\n",
      "*   **Causal Inference:** Moving beyond correlation, AI is being used to infer causal relationships between genes, proteins, and diseases, leading to more precise target identification.\n",
      "\n",
      "**2. Accelerated Target Identification and Validation:**\n",
      "\n",
      "*   **AI for Target Prioritization:** Instead of sifting through thousands of potential targets, AI can analyze vast datasets to identify and rank the most promising targets for intervention, significantly speeding up the early stages of discovery.\n",
      "*   **Predictive Models for Target Druggability:** AI can predict whether a given target is likely to be \"druggable\" ‚Äì meaning a molecule can be designed to effectively bind to it and elicit a therapeutic response.\n",
      "\n",
      "**3. Novel Molecule Design and Generation:**\n",
      "\n",
      "*   **Generative AI for \"De Novo\" Design:** This is a huge area of growth. LLMs and other generative models are being used to design entirely new molecules from scratch, optimized for specific properties like efficacy, safety, and pharmacokinetic profiles. This moves beyond simply screening existing libraries.\n",
      "    *   **Examples:** Designing novel antibodies, small molecules, peptides, and even complex protein structures.\n",
      "*   **Property Prediction:** AI models are becoming highly accurate at predicting various properties of candidate molecules, such as solubility, toxicity, metabolic stability, and binding affinity, before they are even synthesized. This drastically reduces the number of molecules that need to be synthesized and tested experimentally.\n",
      "\n",
      "**4. Optimizing Preclinical and Clinical Trials:**\n",
      "\n",
      "*   **Predicting Trial Success:** AI can analyze historical trial data and preclinical results to predict the likelihood of success for new drug candidates in clinical trials.\n",
      "*   **Smart Patient Selection:** AI can identify patient subgroups most likely to respond to a particular drug, leading to more efficient and ethical clinical trials.\n",
      "*   **Biomarker Discovery:** AI is helping to identify novel biomarkers that can predict drug response or disease progression, which is crucial for precision medicine.\n",
      "*   **Virtual Trials and In Silico Experimentation:** While still evolving, AI is enabling more sophisticated simulations and virtual experiments that can reduce the need for some traditional lab work.\n",
      "\n",
      "**5. Repurposing Existing Drugs:**\n",
      "\n",
      "*   **AI for Drug Repurposing Platforms:** AI can analyze vast amounts of biological, chemical, and clinical data to identify existing drugs that might be effective against new diseases. This can significantly shorten the development timeline as the safety profile of these drugs is already known.\n",
      "\n",
      "**6. Focus on Specific Disease Areas:**\n",
      "\n",
      "*   **Oncology:** AI is making significant strides in identifying new cancer targets, designing personalized cancer therapies, and predicting treatment responses.\n",
      "*   **Neurodegenerative Diseases (e.g., Alzheimer's, Parkinson's):** AI is being used to unravel the complex mechanisms of these diseases and identify novel therapeutic targets.\n",
      "*   **Infectious Diseases:** AI is playing a role in developing new antibiotics, antivirals, and vaccines.\n",
      "\n",
      "**Key Companies and Initiatives:**\n",
      "\n",
      "*   **AI-Native Biotech Companies:** Many startups are built entirely around AI for drug discovery, such as Recursion Pharmaceuticals, Exscientia, Atomwise, Insilico Medicine, and Generate Biomedicines.\n",
      "*   **Big Pharma Partnerships:** Large pharmaceutical companies are increasingly partnering with or acquiring AI-driven drug discovery companies, and investing heavily in their own internal AI capabilities.\n",
      "*   **Academic Research:** Universities and research institutions are at the forefront of developing new AI methodologies and applying them to specific biological challenges.\n",
      "\n",
      "**Challenges Remain:**\n",
      "\n",
      "*   **Data Quality and Accessibility:** High-quality, well-annotated biological data is crucial for training robust AI models.\n",
      "*   **Experimental Validation:** AI predictions still need rigorous experimental validation, which remains a bottleneck.\n",
      "*   **Regulatory Hurdles:** The regulatory pathways for AI-discovered drugs are still being defined.\n",
      "*   **Interpretability and Trust:** Ensuring that AI models are explainable and trustworthy for critical decision-making is an ongoing effort.\n",
      "\n",
      "In summary, AI is fundamentally transforming drug discovery by making it faster, cheaper, and more precise. The ability to analyze massive datasets, design novel molecules, and predict outcomes is leading to a surge in promising drug candidates and a deeper understanding of human health.\n",
      "\n",
      " ### Session: compaction_demo\n",
      "\n",
      "User > Tell me more about the second development you found.\n",
      "gemini-2.5-flash-lite >  You're referring to the **second development** I mentioned, which was **Accelerated Target Identification and Validation**. Let's dive deeper into what that means and why it's so important in drug discovery.\n",
      "\n",
      "**What is a Drug Target?**\n",
      "\n",
      "Before we go further, it's essential to understand what a drug target is. In the context of treating a disease, a drug target is typically a **molecule** (usually a protein, but it can also be a gene or other biological entity) within the body that is **involved in a disease process**. By interacting with this target, a drug can:\n",
      "\n",
      "*   **Block** its activity (e.g., an enzyme that's overactive in a disease).\n",
      "*   **Activate** its activity (e.g., a receptor that's not working properly).\n",
      "*   **Modulate** its activity (increase or decrease its function).\n",
      "\n",
      "Think of it like a lock and key. The disease process is the \"problem,\" and the drug target is the specific \"lock\" that the disease is interacting with. A drug is the \"key\" designed to fit that lock and either jam it, unlock it, or adjust its mechanism to fix the problem.\n",
      "\n",
      "**The Traditional Challenge of Target Identification:**\n",
      "\n",
      "Traditionally, identifying and validating drug targets has been a lengthy, expensive, and often serendipitous process. It involved:\n",
      "\n",
      "1.  **Hypothesis Generation:** Researchers would form hypotheses based on existing biological knowledge and experimental observations about what might be causing a disease.\n",
      "2.  **Experimental Validation:** These hypotheses would then be tested through laborious experiments, often involving genetic manipulation, protein studies, and cell-based assays.\n",
      "3.  **Literature Review:** Extensive review of scientific literature to find clues.\n",
      "4.  **High-Throughput Screening (HTS):** Screening large libraries of compounds to see if they affect a specific biological pathway, which might indirectly point to a target.\n",
      "\n",
      "This process could take many years and a significant amount of resources, with a high failure rate. Many promising leads would fizzle out because the initial hypothesis was incorrect, the experimental data was inconclusive, or the target proved to be difficult to modulate.\n",
      "\n",
      "**How AI Accelerates Target Identification and Validation:**\n",
      "\n",
      "AI, particularly machine learning and deep learning, is revolutionizing this stage by enabling researchers to:\n",
      "\n",
      "1.  **Analyze Vast and Complex Datasets:**\n",
      "    *   **Omics Data:** AI can process and find patterns in enormous datasets from genomics (DNA), transcriptomics (RNA), proteomics (proteins), metabolomics (metabolites), and more. By looking for genes or proteins that are consistently up- or down-regulated in diseased versus healthy states, AI can highlight potential targets.\n",
      "    *   **Electronic Health Records (EHRs):** AI can analyze anonymized patient data from EHRs to identify correlations between genetic predispositions, disease progression, and treatment responses.\n",
      "    *   **Scientific Literature:** Natural Language Processing (NLP) models can \"read\" and synthesize information from millions of research papers, identifying novel connections and potential targets that human researchers might miss.\n",
      "\n",
      "2.  **Prioritize Targets with Higher Likelihood of Success:**\n",
      "    *   **Predictive Models:** AI algorithms can be trained on historical data of successful and failed drug targets. These models can then predict the \"druggability\" of a newly identified target ‚Äì meaning, how likely it is that a molecule can be designed to effectively bind to and modulate it, and whether it's likely to have a beneficial therapeutic effect without causing significant side effects.\n",
      "    *   **Network Analysis:** AI can map out complex biological networks to understand how different molecules interact. This helps identify key nodes (potential targets) that, if modulated, could have a significant impact on the disease pathway.\n",
      "\n",
      "3.  **Identify Novel Mechanisms of Action:**\n",
      "    *   AI can uncover unexpected relationships between biological components, suggesting entirely new ways to approach a disease that might not be obvious through traditional biological intuition.\n",
      "\n",
      "4.  **Automate and Streamline Validation:**\n",
      "    *   While experimental validation is still crucial, AI can help design more efficient experiments by suggesting the most critical genes or proteins to investigate first. It can also analyze experimental readouts more rapidly and identify subtle patterns.\n",
      "\n",
      "**Key Benefits of AI in Target Identification and Validation:**\n",
      "\n",
      "*   **Speed:** Reduces the time from disease understanding to identifying potential targets from years to months or even weeks.\n",
      "*   **Efficiency:** Focuses resources on the most promising targets, reducing wasted effort and investment.\n",
      "*   **Novelty:** Uncovers targets and mechanisms that might be missed by human researchers.\n",
      "*   **Reduced Failure Rates:** By prioritizing more \"druggable\" targets early on, it can lead to a higher success rate in later stages of drug development.\n",
      "\n",
      "**In essence, AI acts as an incredibly powerful \"detective\" and \"strategist\" for drug discovery. It sifts through immense amounts of data to find the most promising \"culprits\" (targets) involved in the \"crime\" (disease) and provides evidence for why they are the right ones to focus on, making the subsequent drug development process much more targeted and likely to succeed.**\n",
      "\n",
      " ### Session: compaction_demo\n",
      "\n",
      "User > Who are the main companies involved in that?\n",
      "gemini-2.5-flash-lite >  You're asking about the companies actively involved in **AI-driven drug discovery**, particularly those making significant strides in **target identification and validation** as we discussed. This is a very active space, and it includes a mix of established pharmaceutical giants and innovative AI-native biotech companies.\n",
      "\n",
      "Here's a breakdown of the main players and categories:\n",
      "\n",
      "**1. AI-Native Biotech Companies (Often Pioneers in This Area):**\n",
      "\n",
      "These companies are founded with AI at their core and are often leading the charge in developing novel AI platforms for drug discovery. Many of them focus heavily on target identification and validation as a foundational step.\n",
      "\n",
      "*   **Recursion Pharmaceuticals:** A leader in using AI and machine learning to map cellular biology and identify new drug targets. They use high-throughput biological imaging and sophisticated algorithms to understand disease at a cellular level.\n",
      "*   **Exscientia:** Focuses on using AI to design novel drug molecules from scratch and also leverages AI for target identification. They aim to automate and accelerate the entire drug discovery and design process.\n",
      "*   **Atomwise:** Primarily known for its AI-powered small molecule drug discovery platform, but their ability to predict how molecules interact with targets also contributes to target validation.\n",
      "*   **Insilico Medicine:** A prominent company using generative AI for target discovery, small molecule generation, and clinical trial prediction. They've been very public about their AI-driven drug candidates moving into clinical trials.\n",
      "*   **Generate Biomedicines:** Uses generative AI to create novel protein therapeutics (like antibodies and enzymes), which inherently requires deep understanding and validation of biological targets.\n",
      "*   **BenevolentAI:** A UK-based company that uses AI to mine vast amounts of scientific literature and other data sources to identify novel drug targets and accelerate R&D.\n",
      "*   **Schr√∂dinger:** While not exclusively an AI company, Schr√∂dinger's physics-based computational platform is highly advanced and integrates machine learning to predict molecular properties and optimize drug candidates, which directly impacts target validation.\n",
      "*   **Relay Therapeutics:** Uses advanced experimental techniques combined with computational approaches to understand protein motion and function, which is critical for identifying and validating targets.\n",
      "\n",
      "**2. Major Pharmaceutical Companies (Investing Heavily and Building Capabilities):**\n",
      "\n",
      "Established pharmaceutical giants are increasingly integrating AI into their R&D pipelines. They are either building their own internal AI capabilities or, more commonly, partnering with or acquiring AI-native companies.\n",
      "\n",
      "*   **Pfizer:** Has been actively investing in AI for various stages of drug discovery, including target identification and clinical trial optimization.\n",
      "*   **Merck (MSD):** Engaged in multiple collaborations and internal initiatives to leverage AI for understanding disease biology and finding new targets.\n",
      "*   **Novartis:** Has a strong focus on AI and data science, using it to accelerate target identification, drug design, and clinical development.\n",
      "*   **AstraZeneca:** Uses AI across its R&D, from target identification to precision medicine applications.\n",
      "*   **Sanofi:** Investing in AI platforms and partnerships to enhance drug discovery and development efficiency.\n",
      "*   **Johnson & Johnson:** Actively exploring AI for target identification, drug design, and personalized medicine.\n",
      "*   **Roche/Genentech:** Known for their strong data science and computational biology efforts, integrating AI into their discovery processes.\n",
      "\n",
      "**3. Technology Giants (Providing AI Infrastructure and Solutions):**\n",
      "\n",
      "While not directly discovering drugs, these companies provide the underlying AI technologies and cloud computing power that enable many of the above companies to operate.\n",
      "\n",
      "*   **Google (DeepMind/Isomorphic Labs):** DeepMind's AlphaFold revolutionized protein structure prediction, which is a crucial component of understanding protein targets. Isomorphic Labs, a Google-affiliated company, is specifically focused on AI for drug discovery.\n",
      "*   **Microsoft:** Offers cloud computing services (Azure) and AI tools that are essential for large-scale data analysis and model training in drug discovery.\n",
      "*   **Amazon (AWS):** Similar to Microsoft, AWS provides the cloud infrastructure and AI/ML services that power many biotech companies.\n",
      "*   **NVIDIA:** Their GPUs are the workhorses for training complex AI models, making them critical for many AI-driven drug discovery efforts.\n",
      "\n",
      "**How They Interact:**\n",
      "\n",
      "*   **Partnerships and Collaborations:** Big Pharma often partners with AI-native biotechs to leverage their specialized platforms.\n",
      "*   **Acquisitions:** Larger companies may acquire successful AI startups to integrate their technology and talent.\n",
      "*   **Internal Development:** Many large pharma companies are building their own in-house AI and data science teams.\n",
      "*   **Platform Providers:** Tech giants offer the essential tools and infrastructure.\n",
      "\n",
      "This is a dynamic and competitive landscape. New companies emerge, partnerships shift, and technological advancements constantly redefine who is at the forefront. However, the companies listed above represent some of the most significant players driving the transformation of drug discovery through AI.\n"
     ]
    }
   ],
   "source": [
    "# Turn 1\n",
    "await run_session(\n",
    "    research_runner_compacting,\n",
    "    \"What is the latest news about AI in healthcare?\",\n",
    "    \"compaction_demo\",\n",
    ")\n",
    "\n",
    "# Turn 2\n",
    "await run_session(\n",
    "    research_runner_compacting,\n",
    "    \"Are there any new developments in drug discovery?\",\n",
    "    \"compaction_demo\",\n",
    ")\n",
    "\n",
    "# Turn 3 - Compaction should trigger after this turn!\n",
    "await run_session(\n",
    "    research_runner_compacting,\n",
    "    \"Tell me more about the second development you found.\",\n",
    "    \"compaction_demo\",\n",
    ")\n",
    "\n",
    "# Turn 4\n",
    "await run_session(\n",
    "    research_runner_compacting,\n",
    "    \"Who are the main companies involved in that?\",\n",
    "    \"compaction_demo\",\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "ac9478c8",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "--- Searching for Compaction Summary Event ---\n",
      "\n",
      "‚úÖ SUCCESS! Found the Compaction Event:\n",
      "  Author: user\n",
      "\n",
      " Compacted information: model_version=None content=None grounding_metadata=None partial=None turn_complete=None finish_reason=None error_code=None error_message=None interrupted=None custom_metadata=None usage_metadata=None live_session_resumption_update=None input_transcription=None output_transcription=None avg_logprobs=None logprobs_result=None cache_metadata=None citation_metadata=None invocation_id='504e6bb8-f9ef-4c12-9f61-f2e78c827d86' author='user' actions=EventActions(skip_summarization=None, state_delta={}, artifact_delta={}, transfer_to_agent=None, escalate=None, requested_auth_configs={}, requested_tool_confirmations={}, compaction={'start_timestamp': 1762954696.487857, 'end_timestamp': 1762954707.086284, 'compacted_content': {'parts': [{'function_call': None, 'code_execution_result': None, 'executable_code': None, 'file_data': None, 'function_response': None, 'inline_data': None, 'text': \"The user inquired about the latest AI news in healthcare. The AI agent provided a comprehensive overview, categorizing advancements into drug discovery, diagnostics/imaging, personalized treatment, operational efficiency, and the growing role of generative AI. Key trends like Explainable AI (XAI), regulatory efforts, ethical considerations, integration challenges, and AI for underserved populations were also highlighted. The agent recommended specific news outlets, journals, conferences, and company announcements for staying updated.\\n\\nFollowing this, the user asked for more details on new developments in drug discovery. The AI agent elaborated on several key areas, including deeper understanding of disease biology, accelerated target identification/validation, novel molecule design, trial optimization, drug repurposing, and AI's application in specific disease areas like oncology and neurodegenerative diseases. The agent also mentioned key companies and initiatives, alongside remaining challenges like data quality and experimental validation.\\n\\nFinally, the user requested more information on the second development mentioned (Accelerated Target Identification and Validation). The AI agent explained what a drug target is and the traditional challenges in identifying them. It then detailed how AI accelerates this process by analyzing vast datasets (omics, EHRs, literature), prioritizing targets with predictive models and network analysis, identifying novel mechanisms, and streamlining validation. The core benefits of AI in this area were emphasized as speed, efficiency, novelty, and reduced failure rates.\", 'thought': None, 'thought_signature': None, 'video_metadata': None}], 'role': 'model'}}, end_of_agent=None, agent_state=None, rewind_before_invocation_id=None) long_running_tool_ids=set() branch=None id='35ff0774-9baa-4405-8ae1-85adf68f2324' timestamp=1762954719.314698\n"
     ]
    }
   ],
   "source": [
    "# Get the final session state\n",
    "final_session = await session_service.get_session(\n",
    "    app_name=research_runner_compacting.app_name,\n",
    "    user_id=USER_ID,\n",
    "    session_id=\"compaction_demo\",\n",
    ")\n",
    "\n",
    "print(\"--- Searching for Compaction Summary Event ---\")\n",
    "found_summary = False\n",
    "for event in final_session.events:\n",
    "    # Compaction events have a 'compaction' attribute\n",
    "    if event.actions and event.actions.compaction:\n",
    "        print(\"\\n‚úÖ SUCCESS! Found the Compaction Event:\")\n",
    "        print(f\"  Author: {event.author}\")\n",
    "        print(f\"\\n Compacted information: {event}\")\n",
    "        found_summary = True\n",
    "        break\n",
    "\n",
    "if not found_summary:\n",
    "    print(\n",
    "        \"\\n‚ùå No compaction event found. Try increasing the number of turns in the demo.\"\n",
    "    )"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "0693ed39",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "‚úÖ Tools created.\n"
     ]
    }
   ],
   "source": [
    "# Define scope levels for state keys (following best practices)\n",
    "USER_NAME_SCOPE_LEVELS = (\"temp\", \"user\", \"app\")\n",
    "\n",
    "\n",
    "# This demonstrates how tools can write to session state using tool_context.\n",
    "# The 'user:' prefix indicates this is user-specific data.\n",
    "def save_userinfo(\n",
    "    tool_context: ToolContext, user_name: str, country: str\n",
    ") -> Dict[str, Any]:\n",
    "    \"\"\"\n",
    "    Tool to record and save user name and country in session state.\n",
    "\n",
    "    Args:\n",
    "        user_name: The username to store in session state\n",
    "        country: The name of the user's country\n",
    "    \"\"\"\n",
    "    # Write to session state using the 'user:' prefix for user data\n",
    "    tool_context.state[\"user:name\"] = user_name\n",
    "    tool_context.state[\"user:country\"] = country\n",
    "\n",
    "    return {\"status\": \"success\"}\n",
    "\n",
    "\n",
    "# This demonstrates how tools can read from session state.\n",
    "def retrieve_userinfo(tool_context: ToolContext) -> Dict[str, Any]:\n",
    "    \"\"\"\n",
    "    Tool to retrieve user name and country from session state.\n",
    "    \"\"\"\n",
    "    # Read from session state\n",
    "    user_name = tool_context.state.get(\"user:name\", \"Username not found\")\n",
    "    country = tool_context.state.get(\"user:country\", \"Country not found\")\n",
    "\n",
    "    return {\"status\": \"success\", \"user_name\": user_name, \"country\": country}\n",
    "\n",
    "\n",
    "print(\"‚úÖ Tools created.\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "cfbd7664",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "‚úÖ Agent with session state tools initialized!\n"
     ]
    }
   ],
   "source": [
    "# Configuration\n",
    "APP_NAME = \"default\"\n",
    "USER_ID = \"default\"\n",
    "MODEL_NAME = \"gemini-2.5-flash-lite\"\n",
    "\n",
    "# Create an agent with session state tools\n",
    "root_agent = LlmAgent(\n",
    "    model=Gemini(model=\"gemini-2.5-flash-lite\", retry_options=retry_config),\n",
    "    name=\"text_chat_bot\",\n",
    "    description=\"\"\"A text chatbot.\n",
    "    Tools for managing user context:\n",
    "    * To record username and country when provided use `save_userinfo` tool. \n",
    "    * To fetch username and country when required use `retrieve_userinfo` tool.\n",
    "    \"\"\",\n",
    "    tools=[save_userinfo, retrieve_userinfo],  # Provide the tools to the agent\n",
    ")\n",
    "\n",
    "# Set up session service and runner\n",
    "session_service = InMemorySessionService()\n",
    "runner = Runner(agent=root_agent, session_service=session_service, app_name=\"default\")\n",
    "\n",
    "print(\"‚úÖ Agent with session state tools initialized!\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "b78c47d9",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      " ### Session: state-demo-session\n",
      "\n",
      "User > Hi there, how are you doing today? What is my name?\n",
      "gemini-2.5-flash-lite >  Hello! I'm doing well, thank you for asking. I can't recall your name at the moment. Can you please tell me what it is?\n",
      "\n",
      "User > My name is Sam. I'm from Poland.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Warning: there are non-text parts in the response: ['function_call'], returning concatenated text result from text parts. Check the full candidates.content.parts accessor to get the full model response.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "gemini-2.5-flash-lite >  It's a pleasure to meet you, Sam! I'll remember that you're from Poland.\n",
      "\n",
      "User > What is my name? Which country am I from?\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Warning: there are non-text parts in the response: ['function_call'], returning concatenated text result from text parts. Check the full candidates.content.parts accessor to get the full model response.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "gemini-2.5-flash-lite >  Your name is Sam and you are from Poland.\n"
     ]
    }
   ],
   "source": [
    "# Test conversation demonstrating session state\n",
    "await run_session(\n",
    "    runner,\n",
    "    [\n",
    "        \"Hi there, how are you doing today? What is my name?\",  # Agent shouldn't know the name yet\n",
    "        \"My name is Sam. I'm from Poland.\",  # Provide name - agent should save it\n",
    "        \"What is my name? Which country am I from?\",  # Agent should recall from session state\n",
    "    ],\n",
    "    \"state-demo-session\",\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "2e621bb8",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Session State Contents:\n",
      "{'user:name': 'Sam', 'user:country': 'Poland'}\n",
      "\n",
      "üîç Notice the 'user:name' and 'user:country' keys storing our data!\n"
     ]
    }
   ],
   "source": [
    "# Retrieve the session and inspect its state\n",
    "session = await session_service.get_session(\n",
    "    app_name=APP_NAME, user_id=USER_ID, session_id=\"state-demo-session\"\n",
    ")\n",
    "\n",
    "print(\"Session State Contents:\")\n",
    "print(session.state)\n",
    "print(\"\\nüîç Notice the 'user:name' and 'user:country' keys storing our data!\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "2d0429d8",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      " ### Session: new-isolated-session\n",
      "\n",
      "User > Hi there, how are you doing today? What is my name?\n",
      "gemini-2.5-flash-lite >  Hello! I'm doing great. I can't remember your name just yet, but I'd be happy to store it if you'd like to share. I can also store your country! \n",
      "\n"
     ]
    }
   ],
   "source": [
    "# Start a completely new session - the agent won't know our name\n",
    "await run_session(\n",
    "    runner,\n",
    "    [\"Hi there, how are you doing today? What is my name?\"],\n",
    "    \"new-isolated-session\",\n",
    ")\n",
    "\n",
    "# Expected: The agent won't know the name because this is a different session"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "01991ce9",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "New Session State:\n",
      "{'user:name': 'Sam', 'user:country': 'Poland'}\n"
     ]
    }
   ],
   "source": [
    "# Check the state of the new session\n",
    "session = await session_service.get_session(\n",
    "    app_name=APP_NAME, user_id=USER_ID, session_id=\"new-isolated-session\"\n",
    ")\n",
    "\n",
    "print(\"New Session State:\")\n",
    "print(session.state)\n",
    "\n",
    "# Note: Depending on implementation, you might see shared state here.\n",
    "# This is where the distinction between session-specific and user-specific state becomes important."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "a8042a39",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": ".venv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.0"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
